BAB VI. KESIMPULAN DAN SARAN
6.2 SARAN
6.2.1. Agar BIA dapat menjadi salah satu alternatif pemeriksaan tambahan dalam menentukan komposisi cairan tubuh dan status nutrisi pada pasien sepsis dan infeksi HIV.
6.2.2. Perlu dilakukan penelitian lebih lanjut dengan desain penelitian kohort prospektif agar dapat menilai apakah terdapat hubungan parameter BIA dengan outcome pasien sepsis dan infeksi HIV.
KEPUSTAKAAN
1. Neviere Remi. Sepsis and systemic inflammatory response syndrome: Definition, epidemiology, and prognosis
2. Guntur A. H. Sepsis. dalam: Sudoyo WA, Buku Ajar Ilmu Penyakit Dalam, jilid III, edisi IV, Jakarta, FKUI, 2006; 1862-655.
3. Guntur A. H. SIRS, sepsis dan syok septik (Imunologi, Diagnosis, Penatalaksanaan). Surabaya, UNS Press. 2008; 1-15.
4. Neviere Remi, Patophysiology of sepsis
5. Joseph M, Lee Ann B, Michael S, et al. Impact of HIV/AIDS on care and outcomes of severe sepsis. Critical care, 2005; 9:623-630.
6. Nasronudin. AIDS-Sepsis: Prinsip pencegahan dan penatalaksanaan. Dalam: Nasronudin, Barakbah J, Eddy S, et al. HIV & AIDS, pendekatan biologi molekuler, klinis, dan sosial. Surabaya. Airlangga University Press. 2007:193-201.
7. Guntur A. H. Imunopatobiologik sepsis dan penatalaksanaannya. Dalam Proceeding Book: Simposium nasional Sepsis dan Antimikrobial terkini. PETRI 2007. Surakarta, Percetakan Surya Abadi. 2007:32-42.
8. Tomkins A, Fiona W. Malnutrition and infection. In Tomkins A and Fiona W. Malnutrition and Infection − A review − Nutrition policy discussion paper No. 5. United Nations Administrative Committee On Coordination − Subcommittee On Nutrition (Acc/Scn). 1989; 12-17.
9. Hsu Jean W.C, Paul B, Dereck M, et al. Macronutrients and HIV/AIDS ; a review of current evidence. WHO. 2005; 1-19
10.Piwoz EG, Elizabeth A.P., HIV/AIDS and Nutrition: a review of the literature and recommendations for nutritional care and support in Sub-Saharan Africa. Support for analysis and research in Africa (SARA) project, 2000:8-21.
11.Ursula G.Kyle, Inguar Bosaeus, Antonio D, et al. Bioelectrical Impedance Analysis- Part I. review of principles and methods. Clinical nutrition, 2004;1226-43
12.Dehghan M, Merchant A.T. Is Bioelectrical Impedance accurate for use in large epidemiological studies?. Nutrition Journal, 2008;1-7
13.Frankenfield D.C, Cooney R.N, Smith J.S. Bioelectrical Impedance Analysis, Plethysmographic analysis of body composition in critically injured and healthy. Am.J.Clin.Nutr 1999;69:426-31
14.Keyle U.G, bosaeus I, De Lorenzo A.D, et al. EPEN Guidelines. Bioelectrical impedance analysis – part II: utilization in clinical practice. Clinical nutrition,2004:2:1430-53
15.Swanson B, Keithley J. Bioelectrical Impedance Analysis (BIA) in HIV Infection: Principal and clinical applications. Journal of The Association of Nurses in AIDS Care. 1998; 9: 49-54
16.Swaraz S, Marx G, Masterson G, et al. Bioelectrical impedance analysis as a predictor for survival in patients with systemic inflammatory response syndrome, critical Care. 2003; 7(Suppl 2): 185
17.Tsoroz G, Paraschos M, Michail M, et al. Comparative evaluation of extracellular mass and body cell mass between patients with SIRS and severe sepsis by bioelectrical impedance analysis. Critical Care 2005; 9 (Suppl 1): 414
18.Ludy M.J, Kristy H, Ploenchan C, et al. Body composition in adult infected with human immunodeficiency virus in Khon Kaen, Thailand. Am J.Trop Med Hyg. 2005; 73: 815-819.
19.Purba D. B. Kadar prokalsitonin sebagai marker dan hubungannya dengan derajat keparahan sepsis. Medan. USU Press. 2010;52-64.
20.Shumei S, Guo, Roger M, et al. Epidemiological applications of Body Composition. The effects and adjustment of measurement errors. Annals New York Academy of Science; 312-16
21.Barbosa-silva M.C, Barros A, Wang.J, et al. Bioelectrical impedance analysis: population reference values for phase angel by age and sex. Am J Clin.Nutr 2005;82:49-52
22.Liedtke R.J. principles of Bioelectrical Impedance Analysis.1997:1-10
23.Gudivaka D, Schoeller A, Kushner R.F, et al. Single and multifrequency model for bioelectrical impedance analysis of body water compartments. J Appl Physol 1999;87:1087-96
24.Duerenberg P, Kotler, Wagner, et al. Validity of body composition methods across ethnic population groups. Acta diabetol. 2003;40:246-49
25.Kaslow J. E. Fluid Assesment with Bioelectrical Impedance Analysis 2010. 26.R. Liedtke. BioImpedance Analysis.
27.Paeratahuls S, Adam LS, Zhai F, etal. Sex difference in measures of body fatness and the possible difference in the effect of dietary on body fatness in men and woman. European journal of clinical nutrition. 1999;53, 865-871.
28.Sungkar T. Perbedaan parameter BIA berdasarkan gender pada populasi sehat di Medan. USU Press. 2010; 19-27.
29.Schwenk A, Ward L.C, Elia G, Scott M. Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia. Infection J. 1998; 26:277-282.
30.Grady C, Mary R, Robin A, et al. Body composition in clinically stable men with HIV infection. Janac. 1996;7:29-38.
31.Swanson B, Ronald C.H, Beverly E.S, et al. Body composition in HIV-infected women. Nutrition. 2000;16:1064-68.
32.Ampel N, Bowers JM. Association of body composition, measured bioelectrical impedance analysis (BIA), nutritional state, and HIV status among HIV-infected men. Int Conf AIDS. 1998;12:845.
33.Highleyman Liz, Nutrition and HIV, Bulletin of Experimental Treatment for AIDS, Winter, 2006; 18-32.
34.Niyongabo T, Melchior J.C, Henzel D, et al, Comparison of Methods for Assesing Nutritional Status in HIV-Infected Adult, Nutrition, 1999; 15: 740-43.
35.Sugondo S. Obesitas, dalam: Sudoyo WA, Buku Ajar Ilmu Penyakit Dalam, jilid III, edisi IV, Jakarta, FKUI, 2006; 1941-55.
36.Nasronudin. Diagnosis infeksi HIV & AIDS. Dalam: Nasronudin, Barakbah J, Eddy S, et al. HIV & AIDS, pendekatan biologi molekuler, klinis, dan sosial. Surabaya. Airlangga University Press. 2007:193-201.
37.Casey Kathleen M, Malnutrition associated with HIV/AIDS. Part one: Definition and scope, epidemiology, and pathophysiology, Journal of Association of Nurses in AIDS Care, 1997: 8; 24-32.
38.Lindsay D, Plank, Andrew B, et al, Sequential changes in the metabolic respone in severely septic patients during the first 23 days after the onset of peritonitis, Annal of Surgery, 1998: 228; 146-52.
39.Finn P.J, Plank L.D, Clark M.A, et al, Progressive cellular dehidraation and proteolisis in critically ill patients, The Lancet, 1996: 347; 654-56.
40.Plank L.D, and Hill G.L, Similarity of change in body composition in intensive care patients folloving severe sepsis or major blunt injury, Annal of the New York Academy of Science, 2006: 904; 592-02.
41.Weisier R.L, Yves S, and David B, Reexamination of relationship of resting metabolic rate to fat-free mass aand to the metabolically active components of fat-free mass in human, Am J Clin Nutr, 1992: 55; 790-94.
42.Cunningham J, A reanalysis of the factors influencing basal metabolic rate in normal adults, The American Journal of Nutrition, 1980: 33; 2372-74.
43.Wang Z, Stanley H, Dympna G, et al, Resting energy expenditure-fat-free mass relationship: new insight provided by body composition modeling, Am J Physiol Endokcrinol Metab, 2000: 279; E539-E545.
44.Johnstone Alexandra M, Sandra D.M, Jacky S Duncan, et al, Factor influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and thyroxine but not sex, ciculaing leptin, or triiodothyronine, Am J Clin Nutr, 2005: 82; 941-48. 45.James John A, Bioelectrical impedance analysis (BIA) may predict AIDS survival,
46.Gupta D, Carolyn A Lammersfeld, Pankaj G Vashi, et al, Bioelectrical impedance phase angle as a prognostic indicator inbreast cancer, BMC Cancer, 2008: 8; 249. AIDS TREATMENT NEWS, Issue 225, June 16, 1995.
47.Schwenk A, Alexander B, Katja R, et al, Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment, Am J Clin Nutr 2000;72:496–501.
48.Kristina Norman, Nicole Stoba¨us, Daniela Zocher, et al, Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer, Am J Clin Nutr 2010;92:612–9.
Lampiran 1. MASTER TABEL PENELITIAN
N0 NAMA KLPK TB BB USIA BMI PHASE
A RMR FFM FFM (%) FAT FAT (%) TBW TBW (%) ECW ECW (%) ICW ICW (%) BCM 1 Carlos M HIV 168 54 24 19.1 4.68 1548 46.73 86.54 7.27 13.46 30.06 55.66 14.77 49.13 15.29 50.86 23.19 2 Abdi I. Nst HIV 163 48 31 18 2.98 1405 42.65 88.85 5.35 11.15 30.55 63.64 21.39 70.01 9.16 29.98 18.09 3 Lamhot L HIV 165 49 32 18 3.63 1330 38.1 77.76 10.9 22.24 25.07 51.16 12.57 50.13 12.5 49.86 19.14 4 Herman P HIV 165 36 30 13.2 2.09 1254 32.87 91.31 3.13 8.69 24.53 68.13 19.62 79.98 4.91 20.01 12.61 5 Sudariawan HIV 165 36 30 13.2 2.09 1254 32.87 91.31 3.13 8.69 24.53 68.13 19.62 79.98 4.91 20.01 12.61 6 Ponten K HIV 165 45 25 16.5 1.19 1464 43.12 95.82 1.88 4.18 31.46 69.91 25.16 79.97 6.3 20.02 16.61 7 Firdaus HIV 160 48 24 18.7 3.82 1420 41.62 86.71 6.38 13.29 26.74 55.7 14.55 54.41 12.19 45.58 19.83 8 Bahagia S HIV 159 51 32 20.1 4.61 1405 44.18 86.63 6.82 13.37 29.47 57.78 15.32 51.98 14.15 48.01 21.68 9 Syafruddin HIV 175 50 41 16.3 4.02 1404 42.99 85.98 7.01 14.02 29.78 59.56 16.92 56.81 12.86 43.18 20.53 10 Minarsen HIV 159 45 36 17.8 4.61 1270 37.89 84.2 7.11 15.8 25.42 56.48 13.21 51.96 12.21 48.03 18.69 11 Robert S HIV 168 55 36 19.4 3.73 1487 47.9 87.09 7.1 12.91 32.51 59.1 18.71 57.55 13.8 42.44 22.59 12 Dhjonyndo HIV 168 55 23 19.4 4.89 1587 48.64 88.44 6.36 11.56 32.99 59.98 17.14 51.95 15.85 48.04 23.93 13 Supriono HIV 173 55 24 18.3 2.32 1669 52.3 95.09 2.7 4.91 37.5 68.18 30 80 7.5 20 19.79 14 Agus Susilo HIV 168 55 36 19.4 3.73 1487 47.9 87.09 7.1 12.91 32.51 59.1 18.71 57.55 13.8 42.44 22.59 15 Yan fredi S HIV 170 62 23 21.4 2.16 1707 55.03 88.76 6.97 11.24 37.3 60.16 28.99 77.72 8.31 22.27 21.27 16 Robinhoot HIV 162 50 28 19 3.36 1469 45.48 90.96 4.52 9.04 32.75 65.5 22.01 67.2 10.74 32.79 19.81 17 Loksa S HIV 170 50 24 17.3 3.81 1519 44.48 88.96 5.52 11.04 30.43 60.86 18.04 59.28 12.39 40.71 20.65 18 M. Aulia HIV 168 40 42 14.1 4.47 1274 37.9 94.75 2.1 5.25 24.84 62.1 14.46 58.21 10.38 41.78 17.38 19 Katinamoi HIV 168 54 25 19.1 3.1 1584 49.25 91.2 4.75 8.8 34.44 63.77 23.38 67.88 11.06 32.11 21.17 20 Bancina HIV 164 45 26 16.7 3.78 1365 38.05 84.56 6.95 15.44 26.04 57.86 14.99 57.56 11.05 42.43 18.03 21 Rahmad H HIV 162 50 28 19 3.36 1469 45.48 90.96 4.52 9.04 32.75 65.5 22.01 67.2 10.74 32.79 19.81 22 Selamat I Non HIV 160 60 50 23.4 2.57 1375 49.23 82.05 10.77 17.95 36.06 60.1 25.41 70.46 10.65 29.53 21.06 23 Akim Trgn Non HIV 175 56 43 18.2 6.83 1540 51.72 92.36 4.28 7.64 39.48 70.5 20.49 51.89 18.99 48.1 26.03 24 Hasanuddin Non HIV 165 65 36 23.8 3.89 1460 47.23 72.66 17.77 27.34 32.85 50.53 15.08 45.9 17.77 54.09 25.18 25 Abubakar Non HIV 168 60 40 21.2 4.43 1515 51.08 85.13 8.92 14.87 35.5 59.16 18.75 52.81 16.75 47.18 25.29
26 Budiman Non HIV 164 50 53 18.5 6.22 1282 43.83 87.66 6.17 12.34 30.33 60.66 14.83 48.89 15.5 51.1 22.15 27 Khairuddin Non HIV 159 70 50 27.6 3.05 1299 45.08 64.4 24.92 35.6 34.58 49.4 17.06 49.33 17.52 50.66 24.51 28 Adul Hat Non HIV 165 60 20 22 7.65 1691 54.36 90.6 5.64 9.4 37.76 62.93 17.22 45.6 20.54 54.39 27.94 29 Suwanto Non HIV 165 58 50 21.3 3.32 1425 50.67 87.36 7.33 12.64 36.23 62.46 23.17 63.95 13.06 36.04 22.86 30 M. Irfan Non HIV 170 55 21 19 3.41 1598 47.88 87.05 7.12 12.95 30.92 56.21 17.54 56.72 13.38 43.27 22.43 31 Suko S Non HIV 165 68 60 24.9 3.68 1355 50.55 74.34 17.45 25.66 37.84 55.64 20.14 53.22 17.7 46.77 25.97 32 Supar Non HIV 168 68 60 24 10.2 1536 60.2 88.53 7.8 11.47 47.56 69.94 21.18 44.53 26.38 55.46 32.28 33 Miran Non HIV 165 50 29 18.3 4.03 1462 44.56 89.12 5.44 10.88 29.56 59.12 16.62 56.22 12.94 43.77 21.04 34 Bono D Non HIV 160 50 51 19.5 3.35 1206 39.8 79.6 10.2 20.4 27.2 54.4 15.22 55.95 11.98 44.04 19.25 35 Rivi H Non HIV 158 50 28 20 5.14 1323 38.17 76.34 11.83 23.66 24.8 49.6 10.52 42.41 14.28 57.58 20.25 36 Tumin Non HIV 160 50 60 19.5 3.3 1176 41.58 83.16 8.42 16.84 29.48 58.96 18.17 61.63 11.31 38.36 19.23 37 Juli Non HIV 165 70 31 25.7 3.42 1751 62.16 88.8 7.84 11.2 47.09 67.27 31.24 66.34 15.85 33.65 27.75 38 Azmi Idris Non HIV 160 65 29 25.3 2.63 1683 58.86 90.55 6.14 9.45 46.7 71.84 37.36 80 9.34 20 22.68 39 Saliman Non HIV 168 60 40 21.2 4.43 1515 51.08 85.13 8.92 14.87 35.5 59.16 18.75 52.81 16.75 47.18 25.29 40 Supriadi Non HIV 165 60 44 22 4.24 1509 53.21 88.68 6.79 11.32 40.28 67.13 24.3 60.32 15.98 39.67 25.16 41 Samidi Non HIV 165 80 58 29.3 4.51 1427 53.95 67.44 26.05 32.56 42.87 53.58 19.58 45.67 23.29 54.32 30.52 42 T. Ganda Non HIV 170 55 60 19 2.01 1308 46.36 84.29 8.64 15.71 32.18 58.5 25.57 79.45 6.61 20.54 17.72
Sambungan lampiran 1. Master Tabel Penelitian
N0 PROTEIN MINERAL MUSCLE TBK GLYCOGEN Hb WBC PCT
(ng/ml) CD4 Absolut KULTUR DARAH DIAGNOSA SEPSIS OUTCOME
1 12.33 4.33 23.21 111.1 424 7.3 3,360 1.22 18 Negative Pneumonia Mati
2 8.95 3.14 17.77 88.2 387 6.4 840 11.8 12 Negative Pneumonia Mati
3 9.64 3.38 18.89 91.7 346 10.2 1,690 0.88 46 Negative Pneumonia Mati
4 6.17 2.16 12.35 62.2 298 13.2 6,100 2.65 4 Strep. Faecalis Pneumonia Mati
5 6.17 2.16 12.35 62.2 298 12.9 22,710 10.7 17 Negative Pneumonia Mati
6 8.62 3.03 16.52 81.9 392 4.96 8,350 60.11 9 Negative Pneumonia Mati
7 11.01 3.86 20.08 95.3 378 8.1 7,300 1.13 3 Negative Pneumonia Hidup
8 10.88 3.82 21.38 104.1 401 10 12,000 2.65 2 Negative Pneumonia Hidup
9 9.77 3.43 19.97 98.9 390 9.4 7,460 0.84 14 Negative Pneumonia Hidup
10 9.22 3.24 18.35 89.7 344 9 5,490 3 6 Negative Pneumonia Hidup
11 11.38 4 22.3 108.9 435 7.6 4,700 0.8 1 Negative Pneumonia Mati
12 11.58 4.06 23.38 114.9 442 12.7 6,800 0.87 10 Staph.
Saprpphyticus
Pneumonia Mati
13 10.95 3.84 20.02 97.6 475 6 1,290 0.87 11 Negative Pneumonia Hidup
14 11.38 4 22.3 108.9 435 11.1 6,140 1.84 144 Negative Pneumonia Mati
15 13.12 4.6 22.19 104.3 500 10.5 20,830 9.25 10 Negative Pneumonia Hidup
16 9.42 3.3 19.27 96.4 413 6.7 1,710 1.37 3 Negative Pneumonia Hidup
17 10.39 3.65 20.37 99.7 404 11.7 24,100 0.88 57 Staph. Epidermidis Pneumonia Hidup
18 9.66 3.39 17.6 83.8 344 10 14,210 24.4 10 Negative Pneumonia Mati
19 10.95 3.85 21.03 103 447 8.3 18,600 3.95 4 Negative Pneumonia Hidup
20 8.88 3.12 17.69 86.9 345 13.6 5,040 0.8 18 Negative Pneumonia Hidup
21 9.42 3.3 19.27 96.4 413 11.9 13,520 0.83 11 Negative Pneumonia Hidup
22 9.74 3.42 20.35 102.8 447 10.8 16,050 5 Staph. Epidermidis Gangren
Diabeticum
Mati
23 9.05 3.18 23.65 125.3 470 8.16 11,600 29.98 Negatif Pneumonia Hidup
24 10.64 3.73 23.83 120.5 429 10.3 21,480 48.45 Negatif Gangren
Diabeticum
Mati
26 9.99 3.51 21.27 106.2 398 3.8 660 46.58 Negatif Pneumonia Hidup
27 7.77 2.73 21.9 117.6 409 12.7 17,950 100 Staph. Epidermidis Pneumonia Mati
28 12.28 4.31 26.68 133.7 494 6.9 14,750 5.01 Negatif Pneumonia Hidup
29 10.68 3.75 22.14 110.9 460 7.1 37,670 2.89 Negatif Urosepsis Mati
30 12.55 4.4 22.76 108 435 15.4 19,570 60.76 Staph. Epidermidis Pneumonia Mati
31 9.4 3.3 23.79 125 459 11.7 10,790 6.07 Strep. Faecalis Urosepsis Hidup
32 9.35 3.28 28.4 154.7 547 9.81 12,300 1.42 Negatif Pneumonia Hidup
33 11.1 3.9 21.02 101.3 405 9.6 16,620 0.88 Staph. Epidermidis Urosepsis Hidup
34 9.32 3.27 18.81 92.7 361 11.7 37,200 100 Negatif Pneumonia Mati
35 9.89 3.47 19.82 96.6 347 7.8 45,970 43.07 Negatif Pneumonia Mati
36 8.95 3.14 18.6 93 378 14.6 7,880 9.73 Negatif Pneumonia Mati
37 11.15 3.91 25.97 135.1 565 7.9 14,540 5.38 Negatif Pneumonia Mati
38 8.99 3.16 21.16 112.3 535 5 64,705 9.05 Negatif selulitis Mati
39 11.52 4.05 24.35 121.6 464 10 18,710 44.22 Negatif Pneumonia Hidup
40 9.56 3.36 23.28 121.8 483 13.5 12,800 12.63 Negatif Pneumonia Hidup
41 8.19 2.88 26.53 146.2 490 8.1 19,070 5.87 Negatif Pneumonia Mati